0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Oral Contraceptive Use and Infectivity of HIV-Seropositive Women

Charles S. Morrison, PhD; Pamela J. Schwingl, PhD
JAMA. 1993;270(19):2298. doi:10.1001/jama.1993.03510190052014.
Text Size: A A A
Published online

To the Editor.  —From a cross-sectional study in Kenya, Clemetson and colleagues1 recently reported an association between oral contraceptive (OC) use, cervical ectopy and pregnancy, and human immunodeficiency virus (HIV) DNA detection in cervical, but not in vaginal, secretions of 97 HIV-seropositive women. They concluded that their data support the hypothesis that these factors increase the infectivity of HIV-seropositive women. Given the need for informed decision making concerning pregnancy and contraception among HIV-infected women, these results could be of considerable importance.Clemetson et al detected HIV DNA in 28 (33%) of 84 cervical samples and 13 (17%) of 77 vaginal samples. The odds ratio was used to assess the strength of the association between HIV DNA and these factors in bivariate and multivariate analyses. From the multivariate analysis, odds ratios from a logistic model regressing HIV DNA in cervical secretions on OC use, pregnancy, cervical ectopy, cervical mucopus, and

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();